Fresenius Kabi White Paper

The Value of Generic Contrast Utilization in Imaging

This white paper examines clinical, operational, and financial considerations related to FDA-approved generic contrast agents for MRI and CT imaging. Topics include supply diversification, implementation strategies, and quality monitoring. Contact your Fresenius Kabi representative or visit GenericContrastAgents.com for more information.

AHRA White Paper Library

The opinions and viewpoints expressed in sponsored White Papers are the sponsor's own and do not reflect the viewpoint of AHRA: The Association for Medical Imaging Management.

View Full List of White Papers